SureTrader SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Entest BioMedical Inc. (ENTBD)

Add ENTBD Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator gotinearly, vegasdrummer, 1-eye-jack, ronrooster, sizzleweed, Kbro13
Search This Board:
Last Post: 7/29/2015 3:54:57 PM - Followers: 457 - Board type: Free - Posts Today: 8






Company Information:                                                      
4700 Spring Street, Suite 304
La Mesa, Calif. 91942
Telephone: 619-644-3344
Fax: 619-330-2328

Web site:


CIK 0001449447

ImenVax (TM)

Immuno-Therapeutic Cancer Treatment for Canines


In the encapsulated ImenVax™ device, a "cocktail" of integral immuno-catalysts are enclosed. From this ImenVax™ device immuno-catalysts are released which activate the patient's immune cell. These immune cells carry on their normal course of activity by entering the lymph nodes and cause T-Cell adaptation. These T-Cells are what attack and kill the tumor. (Figure 1)

Entest BioMedical Inc. (OTCQB: ENTB)is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTCQB: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), cancer immuno-therapies, testing procedures for diabetes and stem cell research applications for diabetes and other illnesses. The Company also is involved with medical device development (including stem cell extraction instrumentation).

Currently, Entest is focused on research and development in areas of COPD and Immuno-Therapeutic Cancer Vaccines. The Company sees applications for its patent pending technologies in both human and animal venues.

Immuno-therapeutic treatment of cancer - The patent pending Entest application involves perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. The treatment process itself will utilize an implantable encapsulation device as the vaccine delivery system and the initial focus will be treatment of cancer in canines. This canine cancer treatment may also provide clinical support for expansion into human cancer treatment.

Chronic Obstructive Pulmonary Disease -There is currently no cure for COPD and therapy is limited to management of the condition and its symptoms. Over the next 5 years, it is estimated that over $170 billion will be spent on treating COPD in the United States. Entest believes its COPD treatment, which utilizes patent pending adult stem cell therapy coupled with photoceutical device enhancement, has the potential to reverse COPD related lung damage as well as alleviate symptoms.

Entest BioMedical was founded for the purpose of providing excellence in biotechnology research (including adult stem cell regenerative treatment). Our objectives go beyond developing single products and procedures. Our mission is to discover and develop new procedures, treatments and medical devices that improve the quality of life. Our efforts revolve around a business focus of developing leading research and technology. Ongoing R&D is paramount to us in developing products and procedures with purpose, products and services that serve the present and help shape the future.



David R. Koos, PhD, DBA - Chairman and CEO, Secretary, Acting CFO
Feng Lin, MD, PhD - Director of Research
Marilyn Panahi - Director of Quality Assurance

 Recent News!

June 1, 2015




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ENTB News: Quarterly Report (10-q) 07/09/2015 05:21:46 PM
ENTB News: Current Report Filing (8-k) 06/26/2015 06:15:40 AM
ENTB News: Current Report Filing (8-k) 05/22/2015 09:13:17 AM
ENTB News: Quarterly Report (10-q) 04/10/2015 09:12:35 AM
#37166  Sticky Note You MUST have all three of the siblings bucks2pennies 07/21/15 02:12:31 PM
#37223   dont think dilution as less than 5k in sizzleweed 07/29/15 03:54:57 PM
#37222   Etrade......OS 17.4M and market cap 287K. Post split JokersWild12 07/29/15 03:35:03 PM
#37221   Anybody watching the O/S since the split. bucks2pennies 07/29/15 03:18:31 PM
#37220   . I hope there is a purpose for sizzleweed 07/29/15 02:52:47 PM
#37219   Just so you know, these stinkies have Brakeman 07/29/15 02:26:21 PM
#37217   obviously easy to drive price down after the sizzleweed 07/29/15 12:11:47 PM
#37216   Good approach. Always a gamble...timing. Here, bucks2pennies 07/29/15 09:54:21 AM
#37215   I've been in this position to many times. 29YEARINVESTOR 07/28/15 07:10:48 PM
#37214   .00019 before RS. bme 07/28/15 01:53:42 PM
#37213   ENTBD. In regards to value, it appears bucks2pennies 07/28/15 01:22:28 PM
#37212   Yep jack ... from HERO to ZERO in ADVFN_franknstein 07/28/15 12:28:33 PM
#37211   ~ ENTBD = .010 -.0099 (-49.75%)! :-( 1-eye-jack 07/28/15 12:25:16 PM
#37210   ENTB NEXT STEP BANKRUPTCY. ITS ALL BAAAADDDD !!!! TTYLXOX parrishilton 07/28/15 12:18:38 PM
#37209   ~ ENTBD = Chart = & the! :-( 1-eye-jack 07/28/15 11:59:18 AM
#37208   Screwed again. This CEO will do this biglued1 07/28/15 10:40:55 AM
#37207   Hurray Paris is back gotinearly 07/28/15 09:51:09 AM
#37206   ENTB HAS ALWAYS BEEN NON PROFITABLE AND A parrishilton 07/28/15 09:35:15 AM
#37205   I went through many articles about all of Brakeman 07/28/15 09:01:25 AM
#37204   Remember all the fun you've had with baseball ADVFN_franknstein 07/27/15 03:54:16 PM
#37203   At least they brought the O/S down with Bgallatin 07/27/15 03:40:45 PM
#37202   ENTBD. Sad isn't it? Even worse is bucks2pennies 07/27/15 03:34:15 PM
#37201   etrade showed a close on Friday of .0004 Crocs69 07/27/15 03:27:01 PM
#37200   The sad thing is that you can't trade ADVFN_franknstein 07/27/15 03:19:36 PM
#37198   huh? Looks like a 33% loss on bucks2pennies 07/27/15 03:04:52 PM
#37197   The price per share before the split was Brakeman 07/27/15 03:00:29 PM
#37196   What was the pps before the split? My bme 07/27/15 02:33:37 PM
#37195   ~ ENTBD = Sad but True! :-( 1-eye-jack 07/27/15 01:05:51 PM
#37194   Looks like a final and ultimate loss of Meach2 07/27/15 01:02:46 PM
#37193   ~ ENTBD = Thank-you,, that is interesting... ;-) 1-eye-jack 07/27/15 12:54:18 PM
#37192   ~ ENTBD = This Will get Short'd Badly! :-( 1-eye-jack 07/27/15 12:52:57 PM
#37191   ~ ENTBD = .0199 +.0197 (+9,850.00%)!! ;-) 1-eye-jack 07/27/15 12:51:42 PM
#37190   ~ ENTBD = Chart = This will Drop 1-eye-jack 07/27/15 12:46:48 PM
#37189   Stocks with pending company transactions are marked with ADVFN_franknstein 07/27/15 12:01:22 PM
#37188   Does anyone know how many shares of ENTB psk3091 07/27/15 07:23:07 AM
#37187   Well, here comes the split. will news accompany sizzleweed 07/26/15 11:12:56 PM
#37186 Shotime66 07/25/15 05:53:23 PM
#37185   Where on this site does it say 1:150 r/s? e2daD 07/24/15 10:36:14 PM
#37184   When you read the many stock blogs about Brakeman 07/24/15 01:40:09 PM
#37183   Well stated. News is on the horizon bucks2pennies 07/24/15 12:36:09 PM
#37182   thanks gotinearly 07/24/15 12:05:15 PM
#37181   Here's link. someone else posted this earlier. Just psk3091 07/24/15 12:03:48 PM
#37180   Moment of Truth now for Koos and ENTB. JokersWild12 07/24/15 11:54:44 AM
#37179   It looks like this is a little surprise gotinearly 07/24/15 11:42:06 AM
#37178   Never understood why ppl buy after a R/S Thrashing21 07/24/15 11:41:46 AM
#37177   Good question, do you have a link so gotinearly 07/24/15 11:23:14 AM
#37176   ENTB. I too have been in and out. bucks2pennies 07/24/15 10:51:58 AM
#37175   Why is ENTB doing a symbol change at psk3091 07/24/15 10:24:23 AM
#37173   ENTB: effective July 27,2015 a one for 150 Renee 07/24/15 09:34:12 AM
#37171   Stabbing a few more ? Brakeman 07/23/15 07:59:02 AM